We found that a synthetic steroidal glycoside SBF-1 inhibited TCA cycle and oxidative phosphorylation (OXPHOS) by blocking mitochondrial localization of HIBCH, and thus showed its remarkable antitumor effects against CRC both in vitro and in vivo. Here, HIBCH is linked to colorectal carcinoma.